Skip to main content

BlackRock, Inc.

Position in EW — Edwards Lifesciences Corp

CIK 2012383 New York, NY

Position in EW

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$4,211,481,905
-$260,896,340 QoQ
Shares Held
52,590,933
+0.2% QoQ
Ownership
9.13%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 91.21450269764182.ToString("F0")% Shared 0.ToString("F0")% None 8.785497302358184.ToString("F0")%

Common Shares in EW Over Time

Shares Held

Position Value (USD)

Derivatives in EW

reported options exposure · as of Mar 31, 2026
CallValue
$11,051,040
CallShares
138,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $66,749,360,208 across 111 Medical Devices names. EW ranks #5 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 EW
Edwards Lifesciences Corp
This page
52,590,933 $4,211,481,905

All Filings in EW

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,211,481,905 52,590,933
2026-03-31 $11,051,040 138,000
2025-12-31 $4,472,378,245 52,461,915
2025-09-30 $4,222,457,823 54,294,173
2025-06-30 $4,352,170,004 55,647,232
2025-03-31 $3,965,496,251 54,711,593
2024-12-31 $4,036,139,279 54,520,320
2024-09-30 $42,530,555 644,500
2024-09-30 $3,602,075,092 54,585,166